Advanced Solid Tumor Clinical Trials in Hangzhou
3 recruitingHangzhou, China
Showing 1–3 of 3 trials
Recruiting
Phase 1
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
Advanced Solid TumorRefractory Hodgkin Lymphoma
FBD Biologics Limited50 enrolled6 locationsNCT06487624
Recruiting
Phase 2
A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors
Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)
AstraZeneca175 enrolled31 locationsNCT06271837
Recruiting
Phase 1Phase 2
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Metastatic Solid TumorsLocally Advanced Solid Tumors
Turning Point Therapeutics, Inc.500 enrolled165 locationsNCT03093116